Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 10 | 0 | 0 | 0 | 34 |
| Gross Profit | 10 | N/A | N/A | N/A | 34 |
| Operating Expenses | 2,255 | 2,622 | 2,504 | 2,165 | 2,980 |
| Operating Income | -2,245 | -2,622 | -2,504 | -2,165 | -2,946 |
| Other Income | 14 | 6 | 8 | -1 | 1 |
| Pre-tax Income | -2,231 | -2,616 | -2,496 | -2,166 | -2,945 |
| Net Income Continuous | -2,231 | -2,616 | -2,496 | -2,166 | -2,945 |
| Net Income | $-2,231 | $-2,616 | $-2,496 | $-2,166 | $-2,945 |
| EPS Basic Total Ops | -20,245.29 | 5,937.04 | -22,560.73 | -29,685.17 | -78,368.84 |
| EPS Basic Continuous Ops | -20,284.11 | 3,383.41 | -22,815.76 | -29,100.73 | -73,588.23 |
| EPS Diluted Total Ops | -20,245.29 | 5,937.04 | -22,560.73 | -29,685.17 | -78,368.84 |
| EPS Diluted Continuous Ops | -20,284.11 | 3,383.41 | -22,815.76 | -29,100.73 | -73,588.23 |
| EBITDA(a) | $-2,231 | $-2,605 | $-2,485 | $-2,145 | $-2,925 |